Opdivo Regains Top-Selling Title, Japan Pharma Market Grows 4.2% in July-September: IQVIA

Japan’s pharma market expanded 4.2% in July-September from the same period last year, with Opdivo (nivolumab) snatching the top-seller position for the first time since October-December 2016, according to data released by IQVIA. Among Japan’s 10 highest-selling drugs (NHI price...read more